Symbol="CERE"
AssetType="Common Stock"
Name="Cerevel Therapeutics Holdings Inc"
Description="Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various therapies for neuroscientific diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1805387"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="131 DARTMOUTH STREET, SUITE 502, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4897894000"
EBITDA="-389763008"
PERatio="None"
PEGRatio="None"
BookValue="2.754"
DividendPerShare="0"
DividendYield="0"
EPS="-2.53"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.319"
ReturnOnEquityTTM="-0.813"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.53"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="37.13"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="6.96"
EVToRevenue="-"
EVToEBITDA="-11.68"
Beta="1.479"
num_52WeekHigh="41.46"
num_52WeekLow="22.63"
num_50DayMovingAverage="32.14"
num_200DayMovingAverage="29.32"
SharesOutstanding="156833000"
DividendDate="None"
ExDividendDate="None"
symbol="CERE"
open="31.55"
high="31.79"
low="31.26"
price="31.60"
volume="342905.00"
latest_trading_day="2023-07-06"
previous_close="31.91"
change="-0.31"
change_percent="-0.9715%"
aroon_positive_momentum_days="52"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="52"
Volume_recent_avg="611696"
Change_recent_avg="0.01"
Delta_recent_avg="1.36"
Variance_recent_avg="0.68"
Change_ratio_recent_avg="-0.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="52"
Aroon_momentum_negative="48"
image_negative_thumbnail_id_1="131"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0045.jpeg"
image_negative_thumbnail_id_2="126"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0050.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="593"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0006.jpeg"
image_positive_thumbnail_id_1="619"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0089.jpeg"
image_positive_thumbnail_id_2="679"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0029.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
